To access this element change to forms mode OFF
Grant Award View - GA187315
Alternative Lengthening of Telomeres (ALT): Target Discovery to...
GA ID:
GA187315
Agency:
Department of Health and Aged Care
Approval Date:
7-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
7-Jun-2021 to 31-May-2024
Value (AUD):
$1,484,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_Childhood_Cancer_Research
Grant Activity:
Alternative Lengthening of Telomeres (ALT): Target Discovery to Treatment
Purpose:
Osteosarcoma is the most common type of primary bone malignancy, with highest incidence in adolescence. Survival has shown little improvement over the last three decades. The majority (greater than60 percent) of osteosarcomas activate the Alternative Lengthening of Telomeres (ALT) pathway. We have discovered a weakness of ALT cells that we aim to exploit through the development of chemical inhibitors that are rapidly toxic to ALT cells. This approach will offer improved treatments for adolescent osteosarcomas.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2020 Childhood Cancer Research Grant Opportunity
Internal Reference ID:
MRF2007488
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA